During progression to NASH, adipose tissues modulate the downstream PPAR-α through ADIPOQ, enhancing the oxidation of fatty acids and glucose uptake in NAFLD. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.